Results 11 to 20 of about 5,063 (159)

Prevalencia de esófago de Barrett: estudio observacional en una clínica de gastroenterología [PDF]

Revista de Gastroenterología de México, 2017
Introducción y objetivos: El esófago de Barrett es una condición que predispone al adenocarcinoma esofágico. Nuestro objetivo fue establecer la prevalencia de esófago de Barrett en nuestro centro, así como los factores asociados a esta condición ...
J.L. Herrera Elizondo, R. Monreal Robles, D. García Compean, E.I. González Moreno, O.D. Borjas Almaguer, H.J. Maldonado Garza, J.A. González González   +6 more
doaj   +2 more sources

Fundamentos de cirugía general : Esófago [PDF]

, 2021
Fundamentos de Cirugía General. Esófago, es una obra que nace de la pasión de autores nacionales e internacionales hacia un órgano frecuentemente olvidado con el único fin de proporcionar un acceso fácil y rápido al conocimiento actualizado.
Borráez Segura, Bernardo Alfonso
core   +1 more source

Minimally invasive techniques for transthoracic oesophagectomy for oesophageal cancer: systematic review and network meta‐analysis

BJS Open, Volume 4, Issue 5, Page 787-803, October 2020., 2020
Minimally invasive and robotic techniques for oesophagectomy are associated with reduced perioperative morbidity and length of hospital stay, with no compromise of oncological outcomes but no improvement in perioperative mortality. There are suggestions of improved long‐term survival with minimally invasive oesophagectomy and robotic minimally invasive
K. Siaw‐Acheampong, S. K. Kamarajah, R. Gujjuri, J. R. Bundred, P. Singh, E. A. Griffiths   +5 more
wiley   +1 more source

Thromboembolic and bleeding complications in patients with oesophageal cancer

BJS (British Journal of Surgery), Volume 107, Issue 10, Page 1324-1333, September 2020., 2020
A total of 511 patients who underwent curative chemoradiotherapy and subsequent tumour resection for oesophageal cancer were reviewed retrospectively for bleeding events and arterial or venous thromboembolism (VTE). During the 2‐year follow‐up, 50 patients (9·8 per cent) developed VTE, 20 (3·9 per cent) arterial thromboembolism, 21 (4·1 per cent) major
F. I. Mulder, A. Hovenkamp, H. W. M. van Laarhoven, H. R. Büller, P. W. Kamphuisen, M. C. C. M. Hulshof, M. I. van Berge Henegouwen, S. Middeldorp, N. van Es   +8 more
wiley   +1 more source

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy

BJS Open, Volume 4, Issue 4, Page 593-600, August 2020., 2020
Following propensity adjustment for stage, age and sex, neoadjuvant therapy was not associated with survival. Tumour regression is a powerful prognostic indicator, and future research should focus on identifying patients who will derive the most benefit from neoadjuvant chemotherapy.
A. G. M. T. Powell, A. Karran, P. Blake, A. Christian, S. A. Roberts, W. G. Lewis   +5 more
wiley   +1 more source

Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review

BJS Open, Volume 4, Issue 4, Page 554-562, August 2020., 2020
This article provides a systematic review of analysis by vibrational spectroscopy (VS) of human blood for cancer diagnosis – a spectral ‘liquid biopsy’. VS showed high potential for cancer diagnosis, but standardized reporting methods and more robust studies are needed before its value in clinical practice can be determined.
D. J. Anderson, R. G. Anderson, S. J. Moug, M. J. Baker   +3 more
wiley   +1 more source

Prognostic and predictive values of tumour budding in stage IV colorectal cancer

BJS Open, Volume 4, Issue 4, Page 693-703, August 2020., 2020
In stage IV colorectal cancer, tumour budding graded by International Tumor Budding Consensus Conference criteria is an important morphological marker that can predict prognosis and, possibly, tumour chemoresistance. The clinical relevance was maintained consistently in both resection subgroups (R0/R1 and R2/unresected).
K. Nagata, E. Shinto, M. Yamadera, T. Shiraishi, Y. Kajiwara, K. Okamoto, S. Mochizuki, K. Hase, Y. Kishi, H. Ueno   +9 more
wiley   +1 more source

Terapia neoadyuvante en cáncer de esófago [PDF]

, 2018
El cáncer de esófago sigue siendo una patología pésimo pronóstico, principalmente por lo tardío del diagnóstico y el consiguiente tratamiento en estadios avanzados.
Cárcamo I., Marcela, Venturelli M., Francisco, Cárcamo I., Carlos, Venturelli L., Aliro   +3 more
core   +1 more source

Factores de riesgo asociados a esófago de Barrett en pacientes hospitalizados

Revista de la Facultad de Medicina Humana, 2020
Objetivo: El objetivo de este artículo es realizar una revisión sistemática de artículos científicos que revelen los factores de riesgo asociados a Esófago de Barrett en pacientes hospitalizados.
Gerard Martín Gómez
doaj   +1 more source

Impact of co‐morbidities on health‐related quality of life 10 years after surgical treatment of oesophageal cancer

BJS Open, Volume 4, Issue 4, Page 601-604, August 2020., 2020
This study investigated the impact of co‐morbidities on health‐related quality of life during long‐term follow‐up after oesophagectomy. The results showed that the substantial impact of co‐morbidities on reported general health might be associated with symptoms and health‐related quality of life 10 years after oesophageal cancer treatment.
F. Klevebro, A. Johar, P. Lagergren
wiley   +1 more source